Track the 삼성제약 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 삼성제약 has recorded 19 reports. The latest transaction was filed on 8 January 2026 (Other). Among the most active insiders: 젬백스. Every trade is openly available.
19
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
5 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.